Accelerate Diagnostics, Inc - Common Stock, $0.001 par value per share (AXDXQ)

CUSIP: 00430H201

Q2 2023 13F Holders as of 30 Jun 2023

Holder snapshot 5 signals
Share change
+205,042
SEC-reported price per share
$0.81
Number of holders
2
Value change
+$166,325
Number of buys
2
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
25,187,879

Security key

00430H201

Report period

Q2 2023

Institutions

2

Top holders

2

Ownership snapshot

Top reported holders of AXDXQ - Accelerate Diagnostics, Inc - Common Stock, $0.001 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
GRIFFIN ASSET MANAGEMENT,...
Disclosed value leader
GRIFFIN ASSET MANAGEMENT,...
Comparable rows
0/15
Latest evidence
19 May 2023
13F 3/4/5 Highest disclosed value: $7,174,444 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

GRIFFIN ASSET MANAGEMENT, INC. has the largest disclosed position value at $7.17M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens GRIFFIN ASSET MANAGEMENT, INC.'s linked filing trail.
Disclosed position value Top 5
GRIFFIN ASSET MANAGEMENT, INC. $7.17M
VANGUARD GROUP INC $2.01M
Birchview Capital, LP $1.58M
ORACLE INVESTMENT MANAGEMENT INC $1.06M
Alyeska Investment Group, L.P. $867.3K

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
GRIFFIN ASSET MANAGEMENT, INC.
13F
Company
13F
—
denominator unverified
$7,174,444
10,249,206 shares
— 31 Mar 2023
VANGUARD GROUP INC
13F
Company
13F
—
denominator unverified
$2,013,734
2,876,763 shares
— 31 Mar 2023
Birchview Capital, LP
13F
Company
13F
—
denominator unverified
$1,577,000
2,252,388 shares
— 31 Mar 2023
ORACLE INVESTMENT MANAGEMENT INC
13F
Company
13F
—
denominator unverified
$1,057,458
1,510,654 shares
— 31 Mar 2023
Alyeska Investment Group, L.P.
13F
Company
13F
—
denominator unverified
$867,290
1,238,986 shares
— 31 Mar 2023
Cannell & Co.
13F
Company
13F
—
denominator unverified
$778,343
1,111,919 shares
— 31 Mar 2023
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2023

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
2
Shares
205,042
Rows available
2
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2023 vs Q3 2025 Across Filers

Q3 2025 holders
0
Q2 2023 holders
2
Holder diff
2
Investor Q3 2025 Shares Q2 2023 Shares Share Diff Share Chg % Q3 2025 value Q2 2023 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .